Table 6.
Summary of Findings for Sensitivity Analyses Testing Validity of Assumptions
| UL motor capacity | UL ability | Comprehensive function | |
|---|---|---|---|
| Acuity of participants | |||
| ≥6 mo post event | 7 trials n=270 SMD=0.52 95% CI, 0.27–0.77 |
6 trials n=180 SMD=0.74 95% CI, 0.43–1.04 |
4 trials n=134 SMD=0.59 95% CI, 0.24–0.93 |
| <6 mo post event | 5 trials n=74 SMD=0.93 95% CI, 0.41–1.45 |
8 trials n=150 SMD=1.00 95% CI, 0.65–1.36 |
2 trials n=63 SMD=0.61 95% CI, 0.10–1.12 |
| Test for sub-group difference | χ2=1.96; p=0.16 | χ2=1.21; p=0.27 | χ2=0.01; p=0.94 |
| Total weeks of CIMT regimen | |||
| 10 | 4 trials n=43 SMD=0.69 95% CI, 0.01–1.38 |
4 trials n=43 SMD=1.18 95% CI, 0.46–1.89 |
Unable to analyze |
| 2 or 3 | 12 trials n=411 SMD=0.39 95% CI, 0.19–0.59 |
7 trials n=235 SMD=0.92 95% CI, 0.65–1.19 |
|
| Test for sub-group difference | χ2=0.71; p=0.40 | χ2=0.44; p=0.51 |
UL=upper limb; SMD=standardized mean difference; CIMT=constraint-induced movement therapy.